Charming Medical Limited
MCTA
$29.36
$1.866.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | -3.28% | -3.28% | 12.00% | 12.00% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -3.28% | -3.28% | 12.00% | 12.00% | |
| Cost of Revenue | 1.72% | 1.72% | 68.40% | 68.40% | |
| Gross Profit | -3.48% | -3.48% | 11.09% | 11.09% | |
| SG&A Expenses | -13.13% | -13.13% | 10.17% | 10.17% | |
| Depreciation & Amortization | -46.63% | -46.63% | -17.89% | -17.89% | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -14.92% | -14.92% | 8.82% | 8.82% | |
| Operating Income | 45.94% | 45.94% | 24.81% | 24.81% | |
| Income Before Tax | 56.75% | 56.75% | 25.68% | 25.68% | |
| Income Tax Expenses | 27.38% | 27.38% | 34.74% | 34.74% | |
| Earnings from Continuing Operations | 64.46% | 64.46% | 24.15% | 24.15% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | 81.01% | 81.01% | 25.21% | 25.21% | |
| EBIT | 45.94% | 45.94% | 24.81% | 24.81% | |
| EBITDA | 23.87% | 23.87% | 13.47% | 13.47% | |
| EPS Basic | 80.30% | 80.30% | 25.41% | 25.41% | |
| Normalized Basic EPS | 76.24% | 76.24% | 28.09% | 28.09% | |
| EPS Diluted | 80.30% | 80.30% | 25.41% | 25.41% | |
| Normalized Diluted EPS | 76.24% | 76.24% | 28.09% | 28.09% | |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |